Induction chemotherapy followed by concurrent standard radiotherapy and daily low-dose cisplatin in locally advanced non-small-cell lung cancer

British Journal of Cancer

Volumn 81, Issue 2, 1999, Pages 310-315

  Ardizzoni, A ^a   Grossi, F ^a   Scolaro, T ^a   Giudici, S ^a   Foppiano, F ^a   Boni, L ^a   Tixi, L ^a   Cosso, M ^a,c   Mereu, C ^b   Ratto, G Battista ^b   Vitale, V ^a   Rosso, R ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c CENTRO DI BIOTECNOLOGIE AVANZATE   (Italy)

Author keywords

Concurrent chemoradiation in NSCLC; Induction chemotherapy; Phase II study

Indexed keywords

CISPLATIN; VINBLASTINE;

ADULT; AGED; ANEMIA; ARTICLE; CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; ESOPHAGITIS; FEMALE; FOLLOW UP; HEMATOLOGY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; IRRADIATION; LEUKOPENIA; LUNG DISEASE; LUNG NON SMALL CELL CANCER; MALE; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SURVIVAL RATE; THORAX;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; COMBINED MODALITY THERAPY; DRUG ADMINISTRATION SCHEDULE; FEASIBILITY STUDIES; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RADIOTHERAPY, HIGH-ENERGY; SURVIVAL ANALYSIS; VINBLASTINE;

EID: 0032847584     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6990693     Document Type: Article

References (24)

1. American Society of Clinical Oncology (1997) Practice guidelines for the treatment of unresectable non-small-cell lung cancer. J Clin Oncol 15: 2996-3018
2. Choy H, DeVore RF 3rd, Hande KR, Porter LL, Rosenblatt P, Yunus F, Schlabach L, Smith C, Shyr Y, LaPorte K and Johnson DH (1997) Preliminary analysis of a phase II study of paclitaxel, carboplatin, and hyperfractionated radiation therapy for locally advanced inoperable non-small-cell lung cancer. Semin Oncol 24: S12-21 S12-26
3. Crinò L, Latini P, Meacci M, Corgna E, Maranzano E, Darwish S, Minotti V, Santucci A and Tonato M (1993) Induction chemotherapy plus high-dose radiotherapy versus radiotherapy alone in locally advanced unresectable non small-cell lung cancer. Ann Oncol 4: 847-851
4. Dewitt L (1987) Combined treatment of radiation and cisdiamminedichloroplatinum (II); a review of experimental and clinical data. Int J Radiat Oncol Biol Phys 13: 403-426
5. Dillman RO, Herndon J, Seagren SL, Eaton WI. Jr and Green MR (1996) Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial. J Natl Cancer Inst 88: 1210-1215
6. Eberhardt W, Wilke H, Stamatis G, Stuschke M, Harstrick A, Menker H, Krause B, Müeller MR, Stahl M, Flasshove M, Budach V, Greschuchna D, Konietzko N, Sack H and Seeber S (1998) Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small-cell lung cancer: mature results of a phase II trial. J Clin Oncol 16: 622-634
7. Frasei G, Comella P, Scoppa G, Guida C, Gravina A, Fiore F, Casaretti R, Daponte A, Parziale A and Comella G (1997) Weekly paclitaxel and cisplatin with concurrent radiotherapy in locally advanced non-small-cell lung cancer: a phase I study. J Clin Oncol 15: 1409-1417
8. Giaccone G, Splinter TA, Debruyne C, Kho GS, Lianes P, van Zandwijk N Pennucci MC, Scagliotti G, van Meerbeeck J, van Hoesel Q, Curran D, Sahmoud T and Postmus PE (1998) Randomised study of paclitaxel-cisplatin versus cisplatin-teniposide in patients with advanced non-small-cell lung cancer. J Clin Oncol 16: 2133-2141
9. Greco FA, Stroup SL, Gray JR and Hainsworth JD (1996) Paclitaxel in combination chemotherapy with radiotherapy in patients with unresectable stage III non small-cell lung cancer. J Clin Oncol 14: 1642-1648
10. Hazuka MB, Crowley JJ, Bunn PA Jr, ORourke M, Braun TJ and Livingston RB (1994) Daily low-dose cisplatin plus concurrent high-dose thoracic irradiation in locally advanced unresectable non-small-cell lung cancer; results of a phase II Southwest Oncology Group study. J Clin Oncol 12: 1814-1820
11. International Commission on Radiation Units and Measurements (1993) Prescribing, Recording, and Reporting Photon Beam Therapy (Report 50)
12. Isokangas OP, Joensuu H, Halme M, Jekunen A and Mattson K (1998) Paclitaxel (Taxol) and carboplatin followed by concomitant paclitaxel, cisplatin and radiotherapy for inoperable stage III NSCLC. Lung Cancer 20: 127-133
13. Jeremic B, Shibamoto Y, Acimovic L and Milisavljevic S (1996) Hyperfractionated radiation therapy with or without concurrent low dose daily carboplatinetoposíde for stage III non-small-cell lung cancer: a randomized study. J Clin Oncol 14: 1065-1070
14. Le Chevalier T, Arriagada R, Quoix E, Ruffie P, Martin M, Tarayre M, Lacombe-Terrier MJ, Douillard JY and Laplanche A (1991) Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients. J Natl Cancer Inst 83; 417-423
15. Lee JS, Scott C, Komaki R, Fossella FV, Dundas GS, McDonald S, Byhardt RW and Curran WJ Jr (1996) Concurrent chemoradiation therapy with oral etoposide and cisplatin for locally advanced inoperable non small-cell lung cancer: RTOG protocol 91-06. J Clin Oncol 14: 1055-1064
16. Non-small Cell Lung Cancer Collaborative Group (1995) Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised trials. BMJ 311: 899-909
17. Perez CA, Pajak TF, Rubin P, Simpson JR, Mohiuddin M, Brady LW, Perez-Tamayo R and Rotman M (1987) Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy. Report by the Radiation Therapy Oncology Group. Cancer 59: 1874-1881
18. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J and Smith PG (1977) Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II Analysis and examples. Br J Cancer 35: 1-39
19. Reckzeh B, Merte H, Pflüger KH, Pfab R, Wolf M and Havemann K (1996) Severe lymphocytopenia and interstitial pneumonia in patients treated with paclitaxel and simultaneous radiotherapy for non-small-cell lung cancer. J Clin Oncol 14: 1071-1076
20. Sause WT, Scott C, Taylor S, Johnson H, Livingston R, Komaki R, Emami B, Curran WJ, Byhardt RW, Turrisi AT, Rashid Dar A and Cox JD (1995) Radiation therapy oncology group (RTOG) 88-08 and eastern cooperative oncology group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer. J Natl Cancer 87: 198-205
21. Schaake-Koning C, van den Bogaert W, Dalesio O, Festen J, Hoogenhout J, van Houtte P, Kirkpatrick A, Koolen M, Maat B, Nijs A, Renaud A, Rodrigus P, Schuster-Uitterhoeve L, Sculier J-P, van Zandwijk N and Bartelink H (1992) Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. N Engl J Med 326: 524-530
22. Simon R (1989) Optimal two-stage design for phase II clinical trials. Controlled Clin Trials 10: 1-10
23. Soresi E, Clerici M, Grilli R, Borghini E, Zucali R, Leoni M, Botturi M, Vergari C, Luporini G and Scoccia S (1988) A randomized clinical trial comparing radiation Therapy vs radiation therapy plus cis-dichlorodiammine platinum (II) in the treatment of locally advanced non-small cell lung cancer. Semin Oncol 15(suppl 7): 20-25
24. WHO (1979) WHO Handbook for Reporting Results of Cancer Treatment. World Health Organization; Geneva